Minnesota HF2533 expands prior authorization requirements for certain mental health drugs.

Minnesota HF2533 amends the state's statutes to expand prior authorization requirements for certain mental health drugs. The bill specifies that prior authorization may be required for certain drugs, including brand-name drugs when a generic equivalent is available. It also mandates that the commissioner provide information to the Formulary Committee on the impact of placing a drug on prior authorization. The commissioner may require prior authorization for a period not exceeding 180 days for any drug approved by the FDA after July 1, 2005.

Minnesota HF2533 expands prior authorization requirements for certain mental health drugs.

Minnesota HF2533 amends the state's statutes to expand prior authorization requirements for certain mental health drugs. The bill specifies that prior authorization may be required for certain drugs, including brand-name drugs when a generic equivalent is available. It also mandates that the commissioner provide information to the Formulary Committee on the impact of placing a drug on prior authorization. The commissioner may require prior authorization for a period not exceeding 180 days for any drug approved by the FDA after July 1, 2005.